Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions

Chronic muscle injuries, such as massive rotator cuff tears, are associated with progressive muscle wasting, fibrotic scarring, and intramuscular fat accumulation. While progenitor cell subsets are usually studied in culture conditions that drive either myogenic, fibrogenic, or adipogenic differenti...

Full description

Bibliographic Details
Main Authors: Angela Li, Madhavan Anbuchelvan, Amir Fathi, Maya Abu-Zahra, Denis Evseenko, Frank A. Petrigliano, Ayelet Dar
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1173794/full
_version_ 1797845002041163776
author Angela Li
Madhavan Anbuchelvan
Amir Fathi
Maya Abu-Zahra
Denis Evseenko
Denis Evseenko
Frank A. Petrigliano
Ayelet Dar
author_facet Angela Li
Madhavan Anbuchelvan
Amir Fathi
Maya Abu-Zahra
Denis Evseenko
Denis Evseenko
Frank A. Petrigliano
Ayelet Dar
author_sort Angela Li
collection DOAJ
description Chronic muscle injuries, such as massive rotator cuff tears, are associated with progressive muscle wasting, fibrotic scarring, and intramuscular fat accumulation. While progenitor cell subsets are usually studied in culture conditions that drive either myogenic, fibrogenic, or adipogenic differentiation, it is still unknown how combined myo-fibro-adipogenic signals, which are expected to occur in vivo, modulate progenitor differentiation. We therefore evaluated the differentiation potential of retrospectively generated subsets of primary human muscle mesenchymal progenitors in multiplexed conditions in the presence or absence of 423F drug, a modulator of gp130 signaling. We identified a novel CD90+CD56− non-adipogenic progenitor subset that maintained a lack of adipogenic potential in single and multiplexed myo-fibro-adipogenic culture conditions. CD90−CD56− demarcated fibro-adipogenic progenitors (FAP) and CD56+CD90+ progenitors were typified as myogenic. These human muscle subsets exhibited varying degrees of intrinsically regulated differentiation in single and mixed induction cultures. Modulation of gp130 signaling via 423F drug mediated muscle progenitor differentiation in a dose-, induction-, and cell subset-dependent manner and markedly decreased fibro-adipogenesis of CD90−CD56− FAP. Conversely, 423F promoted myogenesis of CD56+CD90+ myogenic subset, indicated by increased myotube diameter and number of nuclei per myotube. 423F treatment eliminated FAP-derived mature adipocytes from mixed adipocytes-FAP cultures but did not modify the growth of non-differentiated FAP in these cultures. Collectively, these data demonstrate that capability of myogenic, fibrogenic, or adipogenic differentiation is largely dependent on the intrinsic features of cultured subsets, and that the degree of lineage differentiation varies when signals are multiplexed. Moreover, our tests performed in primary human muscle cultures reveal and confirm the potential triple-therapeutic effects of 423F drug which simultaneously attenuates degenerative fibrosis, fat accumulation and promotes myo-regeneration.
first_indexed 2024-04-09T17:31:31Z
format Article
id doaj.art-7d5dd77d2da74d78bd388082b543cf9c
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-09T17:31:31Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-7d5dd77d2da74d78bd388082b543cf9c2023-04-18T04:59:54ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-04-011110.3389/fcell.2023.11737941173794Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditionsAngela Li0Madhavan Anbuchelvan1Amir Fathi2Maya Abu-Zahra3Denis Evseenko4Denis Evseenko5Frank A. Petrigliano6Ayelet Dar7Department of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Stem Cell Research and Regenerative Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesChronic muscle injuries, such as massive rotator cuff tears, are associated with progressive muscle wasting, fibrotic scarring, and intramuscular fat accumulation. While progenitor cell subsets are usually studied in culture conditions that drive either myogenic, fibrogenic, or adipogenic differentiation, it is still unknown how combined myo-fibro-adipogenic signals, which are expected to occur in vivo, modulate progenitor differentiation. We therefore evaluated the differentiation potential of retrospectively generated subsets of primary human muscle mesenchymal progenitors in multiplexed conditions in the presence or absence of 423F drug, a modulator of gp130 signaling. We identified a novel CD90+CD56− non-adipogenic progenitor subset that maintained a lack of adipogenic potential in single and multiplexed myo-fibro-adipogenic culture conditions. CD90−CD56− demarcated fibro-adipogenic progenitors (FAP) and CD56+CD90+ progenitors were typified as myogenic. These human muscle subsets exhibited varying degrees of intrinsically regulated differentiation in single and mixed induction cultures. Modulation of gp130 signaling via 423F drug mediated muscle progenitor differentiation in a dose-, induction-, and cell subset-dependent manner and markedly decreased fibro-adipogenesis of CD90−CD56− FAP. Conversely, 423F promoted myogenesis of CD56+CD90+ myogenic subset, indicated by increased myotube diameter and number of nuclei per myotube. 423F treatment eliminated FAP-derived mature adipocytes from mixed adipocytes-FAP cultures but did not modify the growth of non-differentiated FAP in these cultures. Collectively, these data demonstrate that capability of myogenic, fibrogenic, or adipogenic differentiation is largely dependent on the intrinsic features of cultured subsets, and that the degree of lineage differentiation varies when signals are multiplexed. Moreover, our tests performed in primary human muscle cultures reveal and confirm the potential triple-therapeutic effects of 423F drug which simultaneously attenuates degenerative fibrosis, fat accumulation and promotes myo-regeneration.https://www.frontiersin.org/articles/10.3389/fcell.2023.1173794/fullhuman muscle mesenchymal subsetsskeletal muscle differentiationCD90gp130 signalingmyo-fibro-adipogenesisin vitro drug screening
spellingShingle Angela Li
Madhavan Anbuchelvan
Amir Fathi
Maya Abu-Zahra
Denis Evseenko
Denis Evseenko
Frank A. Petrigliano
Ayelet Dar
Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
Frontiers in Cell and Developmental Biology
human muscle mesenchymal subsets
skeletal muscle differentiation
CD90
gp130 signaling
myo-fibro-adipogenesis
in vitro drug screening
title Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
title_full Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
title_fullStr Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
title_full_unstemmed Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
title_short Distinct human skeletal muscle-derived CD90 progenitor subsets for myo-fibro-adipogenic disease modeling and treatment in multiplexed conditions
title_sort distinct human skeletal muscle derived cd90 progenitor subsets for myo fibro adipogenic disease modeling and treatment in multiplexed conditions
topic human muscle mesenchymal subsets
skeletal muscle differentiation
CD90
gp130 signaling
myo-fibro-adipogenesis
in vitro drug screening
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1173794/full
work_keys_str_mv AT angelali distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT madhavananbuchelvan distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT amirfathi distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT mayaabuzahra distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT denisevseenko distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT denisevseenko distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT frankapetrigliano distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions
AT ayeletdar distincthumanskeletalmusclederivedcd90progenitorsubsetsformyofibroadipogenicdiseasemodelingandtreatmentinmultiplexedconditions